The LC-MS/MS analysis showed that the TFCP2 could interact with ITGA2; this interaction was identified by detecting the peptides of TFCP2 (Fig. 6a and b), which had been verified using immunoprecipitation assays in the pancreatic cancer cells (Fig. 6c). Here, TFCP2 is linked to familial pancreatic carcinoma.